Melexis NV
MELE: XBRU (BEL)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| xG> | LOCK|wYx%< | LOCK|V&t@y&> |
Melexis Earnings: Automotive Chip Demand Shows First Signs of Cycle Improvement
In its first-quarter update, Melexis maintained its outlook and expects second-half sales to be higher than the first half. We expect second-half sales to be up 10% sequentially to around EUR 450 million, with any sharper recovery likely happening in 2027.
